Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China · Delayed Price · Currency is CNY 9.15
-0.05 (-0.54%)
May 20, 2026, 11:30 AM CST
SHA:600420 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 718.59 | 941.6 | 1,084 | 691.88 | 627.79 | 568.28 |
Depreciation & Amortization | 710.1 | 710.1 | 772.32 | 818.89 | 842.49 | 820.27 |
Other Amortization | 13.43 | 13.43 | 5.98 | 6.36 | 6.06 | 10.48 |
Loss (Gain) From Sale of Assets | 2.65 | 2.65 | 31.31 | 31.85 | 1.1 | -0.2 |
Asset Writedown & Restructuring Costs | 32.79 | 32.79 | 28.26 | 13.13 | 3.43 | 135.66 |
Loss (Gain) From Sale of Investments | -133.9 | -133.9 | -64.11 | -27.45 | -2.34 | 24.04 |
Provision & Write-off of Bad Debts | 15.67 | 15.67 | -2.36 | -18.05 | -17.59 | 24.87 |
Other Operating Activities | -147.7 | 297.41 | 427.46 | 399.15 | 393.7 | 405.67 |
Change in Accounts Receivable | 187.08 | 187.08 | 732.85 | 485.43 | 463.12 | -921.35 |
Change in Inventory | 485.71 | 485.71 | 60.54 | 163.27 | 625.24 | 195.31 |
Change in Accounts Payable | -833.49 | -833.49 | -918.52 | -832.62 | -30.39 | 444.18 |
Operating Cash Flow | 1,030 | 1,698 | 2,256 | 1,720 | 2,856 | 1,680 |
Operating Cash Flow Growth | -44.31% | -24.73% | 31.13% | -39.76% | 70.01% | 7.66% |
Capital Expenditures | -267.61 | -263.83 | -219.77 | -357.19 | -307.44 | -521.44 |
Sale of Property, Plant & Equipment | 4.73 | 6.15 | 21.95 | 10.96 | 5 | 3.72 |
Divestitures | 102.6 | 102.6 | - | - | - | - |
Investment in Securities | 2.75 | 3.03 | 3 | 2.01 | - | 1.14 |
Other Investing Activities | -1,847 | -2,240 | -661.4 | -1,019 | - | 8.31 |
Investing Cash Flow | -2,005 | -2,392 | -856.23 | -1,363 | -302.44 | -508.28 |
Long-Term Debt Issued | - | - | 50 | 45 | 2,346 | 3,685 |
Total Debt Issued | - | - | 50 | 45 | 2,346 | 3,685 |
Long-Term Debt Repaid | - | -1,060 | -61.44 | -774.23 | -3,203 | -3,402 |
Total Debt Repaid | -60.3 | -1,060 | -61.44 | -774.23 | -3,203 | -3,402 |
Net Debt Issued (Repaid) | -60.3 | -1,060 | -11.44 | -729.23 | -856.83 | 282.87 |
Issuance of Common Stock | - | - | - | - | 1,188 | - |
Common Dividends Paid | -396.5 | -427.9 | -300.68 | -189.35 | -184.7 | -212.46 |
Other Financing Activities | -76.72 | -154.25 | -103.3 | -174.8 | -581.78 | -732.81 |
Financing Cash Flow | -533.53 | -1,642 | -415.42 | -1,093 | -435.32 | -662.41 |
Foreign Exchange Rate Adjustments | -2.99 | 15.34 | 29.63 | 32.07 | 94.24 | -40.08 |
Net Cash Flow | -1,511 | -2,321 | 1,014 | -703.83 | 2,212 | 468.9 |
Free Cash Flow | 762.35 | 1,434 | 2,036 | 1,363 | 2,548 | 1,158 |
Free Cash Flow Growth | -53.31% | -29.56% | 49.37% | -46.50% | 120.01% | -2.03% |
Free Cash Flow Margin | 8.64% | 15.32% | 18.62% | 11.29% | 19.66% | 8.31% |
Free Cash Flow Per Share | 0.57 | 1.07 | 1.52 | 1.07 | 2.20 | 0.98 |
Cash Income Tax Paid | 609.23 | 608.01 | 693.04 | 751.63 | 617.65 | 696.29 |
Levered Free Cash Flow | -936.14 | 873.69 | 1,679 | 1,806 | 1,634 | 621.88 |
Unlevered Free Cash Flow | -933.94 | 876.43 | 1,702 | 1,842 | 1,701 | 690.92 |
Change in Working Capital | -181.65 | -181.65 | -26.52 | -195.37 | 1,001 | -309.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.